Navigation Links
Microfluidics International Corporation to Report Third Quarter 2010 Financial Results on November 16, 2010
Date:11/9/2010

NEWTON, Mass., Nov. 9, 2010 /PRNewswire-FirstCall/ -- Microfluidics International Corporation (OTC Bulletin Board: MFLU) announced today the Company will release third quarter 2010 financial results on Tuesday, November 16, 2010, at 8:30am ET.

Michael C. Ferrara, President and Chief Executive Officer, and Peter F. Byczko, Vice President of Finance and Chief Accounting Officer, will host a conference call and live audio webcast.

Participants are invited to attend the call by visiting www.microfluidicscorp.com/investors and clicking on the webcast link, or by dialing 800.591.6945 (within the United States) or +1 617.614.4911 (outside the United States). The passcode is 16352701.

A replay will be available for one week beginning approximately two hours after the live call. To access the replay, dial 888.286.8010 (within the United States) or +1 617.801.6888 (outside the United States). The passcode is 87175046.

ABOUT MICROFLUIDICS INTERNATIONAL CORPORATIONMicrofluidics International Corporation (OTCBB: MFLU) is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, cell disruption and continuous crystallization. Used by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research and develop innovative products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results. To learn more, visit www.microfluidicscorp.com.Contact:Peter F. ByczkoVice President of Finance and Chief Accounting Officer617-969-5452 x243pbyczko@mfics.com
'/>"/>

SOURCE Microfluidics International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Microfluidics Enters into Exclusive Partnership with ATS Scientific to Expand Distribution in Canada
2. Microfluidics International Corporation to Report Fourth Quarter and Year-end 2009 Financial Results on February 23, 2010
3. Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results
4. Microfluidics Announces Two New Board Members
5. Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
9. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
10. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
11. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):